Article
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.
Oncotarget - 23 Feb 2016
Hou Hsin-An, Liu Chieh-Yu, Kuo Yuan-Yeh, Chou Wen-Chien, Tsai Cheng-Hong, Lin Chien-Chin, Lin Liang-In, Tseng Mei-Hsuan, Chiang Ying-Chieh, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Li Chi-Cheng, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Chen Chien-Yuan, Lin Chien-Ting, Wu Shang-Ju, Tsay Woei, Tien Hwei-Fang
Abstract excerpt
Mutations in splicing factor (SF) genes are frequently detected in myelodysplastic syndrome, but the prognostic relevance of these genes mutations in acute myeloid leukemia (AML) remains unclear. In this study, we investigated mutations of three SF genes, SF3B1, U2AF1 and SRSF2, by Sanger sequencing in 500 patients with de novo AML and analysed their clinical relevance. SF mutations were identified in 10.8% of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.